208 related articles for article (PubMed ID: 16095126)
1. Behçet's disease: treatment of mucocutaneous lesions.
Alpsoy E
Clin Exp Rheumatol; 2005; 23(4):532-9. PubMed ID: 16095126
[TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous lesions of Behcet's disease.
Alpsoy E; Zouboulis CC; Ehrlich GE
Yonsei Med J; 2007 Aug; 48(4):573-85. PubMed ID: 17722228
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cyclosporine on mucocutaneous manifestations of Behçet's disease.
Avci O; Gürler N; Güneş AT
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):796-7. PubMed ID: 9146551
[No Abstract] [Full Text] [Related]
4. The spectrum of mucocutaneous manifestations in Adamantiades-Behçet's disease in Greece.
Vaiopoulos G; Konstantopoulou P; Evangelatos N; Kaklamanis PH
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):434-8. PubMed ID: 19758264
[TBL] [Abstract][Full Text] [Related]
5. A double-blind trial of depot corticosteroids in Behçet's syndrome.
Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
[TBL] [Abstract][Full Text] [Related]
6. [Mucocutaneous involvement in Behçet's disease].
Touraine R
J Mal Vasc; 1988; 13(3):220-1. PubMed ID: 3171404
[TBL] [Abstract][Full Text] [Related]
7. Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study.
Melikoglu M; Fresko I; Mat C; Ozyazgan Y; Gogus F; Yurdakul S; Hamuryudan V; Yazici H
J Rheumatol; 2005 Jan; 32(1):98-105. PubMed ID: 15630733
[TBL] [Abstract][Full Text] [Related]
8. Histopathologic study of cutaneous lesions in Behçet's syndrome.
Chun SI; Su WP; Lee S
J Dermatol; 1990 Jun; 17(6):333-41. PubMed ID: 2384635
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Hotline. Oral allicin in the treatment of Behcet's disease through attenuating oxidative stress: A pilot study in 20 patients with mucocutaneous lesions.
Zhong J; Xian D; Xiong X; Liu J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723197
[TBL] [Abstract][Full Text] [Related]
10. [Behçet's disease - Infliximab in the treatment of mucocutaneous manifestations].
Lestre S; Trindade F; Martins A; Baptista J; Feio AB; Lopes MJ
Acta Reumatol Port; 2009; 34(4):633-40. PubMed ID: 20852576
[TBL] [Abstract][Full Text] [Related]
11. Vasculitis and oral and genital ulcers: Behçet's syndrome or HIV infection?
Olivé A; Fuente MJ; Veny A; Romeu J
Clin Exp Rheumatol; 1999; 17(1):124. PubMed ID: 10084048
[No Abstract] [Full Text] [Related]
12. Behçet's disease: A profile of mucocutaneous features.
Kerkeni N; Zaraa I; Ayachi J; El Euch D; Mokni M; Ben Osman A
Acta Dermatovenerol Alp Pannonica Adriat; 2010; 19(2):11-5. PubMed ID: 20664915
[TBL] [Abstract][Full Text] [Related]
13. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha treatment of Behçet's disease.
O'Duffy JD; Calamia K; Cohen S; Goronzy JJ; Herman D; Jorizzo J; Weyand C; Matteson E
J Rheumatol; 1998 Oct; 25(10):1938-44. PubMed ID: 9779847
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the treatment of skin and mucosal lesions in Behçet's disease: A secondary publication.
Nakamura K; Iwata Y; Asai J; Kawakami T; Tsunemi Y; Takeuchi M; Mizuki N; Kaneko F;
J Dermatol; 2020 Mar; 47(3):223-235. PubMed ID: 31907947
[TBL] [Abstract][Full Text] [Related]
16. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.
Mumcu G; Inanç N; Özdemir FT; Tulunay A; Ekşioğlu-Demiralp E; Ergun T; Direskeneli H
Int J Dermatol; 2013 Dec; 52(12):1561-6. PubMed ID: 23879671
[TBL] [Abstract][Full Text] [Related]
17. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.
Aikawa NE; Gonçalves C; Silva CA; Gonçalves C; Bonfá E; de Carvalho JF
Rheumatol Int; 2011 Aug; 31(8):1097-9. PubMed ID: 20012049
[TBL] [Abstract][Full Text] [Related]
18. Behçet's disease in South African blacks: report of five cases.
Jacyk WK
J Am Acad Dermatol; 1994 May; 30(5 Pt 2):869-73. PubMed ID: 8169265
[TBL] [Abstract][Full Text] [Related]
19. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Mangelsdorf HC; White WL; Jorizzo JL
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):745-50. PubMed ID: 8632067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
